SUPN Supernus Pharmaceuticals PE ratio, current and historical analysis
The current P/E ratio for Supernus Pharmaceuticals stock as of Feb 21, 2025 is 30.6. This is calculated based on the TTM EPS of $1.08 and the stock price of $33.05 per share.
SUPN PE ratio history
The average historical PE ratio of Supernus Pharmaceuticals for the last ten years is 76.32. The current price-to-earnings ratio of 30.6 is 60% less than the historical average. Analyzing the last ten years, SUPN's PE ratio reached its highest point in the Dec 2023 quarter at 1,447, when the price was $28.94 and the EPS was $0.02. The lowest point was recorded in the Mar 2020 quarter, when it reached 8.14 with a price of $17.99 and an EPS of $2.21.
Supernus Pharmaceuticals PE ratio by year
Maximum annual increase: 4,483.47% in 2023
Maximum annual decrease: -70.39% in 2016
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | 1,447 | 4,483.47% | $28.94 | $0.02 |
| 2022 | 31.57 | 9.35% | $35.67 | $1.13 |
| 2021 | 28.87 | 176.53% | $29.16 | $1.01 |
| 2020 | 10.44 | -4.92% | $25.16 | $2.41 |
| 2019 | 10.98 | -29.62% | $23.72 | $2.16 |
| 2018 | 15.6 | -55.77% | $33.22 | $2.13 |
| 2017 | 35.27 | 157.07% | $39.85 | $1.13 |
| 2016 | 13.72 | -70.39% | $25.25 | $1.84 |
| 2015 | 46.34 | N/A | $13.44 | $0.29 |
| 2014 | N/A | N/A | $8.3 | -$0.26 |
| 2013 | N/A | N/A | $7.54 | -$2.9 |
| 2012 | N/A | N/A | $7.17 | -$2.72 |
| 2011 | N/A | N/A | N/A | $31.39 |
| 2010 | N/A | N/A | N/A | -$26.38 |
| 2009 | N/A | N/A | N/A | -$2.1 |
Supernus Pharmaceuticals PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | 28.87 | -90.29% | $31.18 | $1.08 |
| Jun 2024 | 297.22 | N/A | $26.75 | $0.09 |
| Mar 2024 | N/A | N/A | $34.11 | -$0.29 |
| Dec 2023 | 1,447 | 2,366.76% | $28.94 | $0.02 |
| Sep 2023 | 58.66 | 54.17% | $27.57 | $0.47 |
| Jun 2023 | 38.05 | 0.82% | $30.06 | $0.79 |
| Mar 2023 | 37.74 | 19.54% | $36.23 | $0.96 |
| Dec 2022 | 31.57 | -33.79% | $35.67 | $1.13 |
| Sep 2022 | 47.68 | 79.72% | $33.85 | $0.71 |
| Jun 2022 | 26.53 | 14.11% | $28.92 | $1.09 |
| Mar 2022 | 23.25 | -19.47% | $32.32 | $1.39 |
| Dec 2021 | 28.87 | 67.75% | $29.16 | $1.01 |
| Sep 2021 | 17.21 | 6.17% | $26.67 | $1.55 |
| Jun 2021 | 16.21 | 30.62% | $30.79 | $1.9 |
| Mar 2021 | 12.41 | 18.87% | $26.18 | $2.11 |
SUPN average PE ratio chart
The current PE ratio of SUPN is under its 3, 5 and 10-year averages.
SUPN PE vs peers
SUPN's PE ratio is less than its peer stocks LLY and ABT, but it is above JNJ's and UTHR's. Supernus Pharmaceuticals is currently trading at a lower PE ratio (30.6) than its peers average of 39.45.
| Stock name | PE ratio | Market cap |
|---|---|---|
| UTHR UNITED THERAPEUTICS Corp | 14.85 | $16.12B |
| JNJ Johnson & Johnson | 27.79 | $390.76B |
| SUPN Supernus Pharmaceuticals Inc | 30.6 | $1.82B |
| ABT Abbott Laboratories | 40.88 | $234.01B |
| LLY ELI LILLY & Co | 74.29 | $828.4B |
| BMY Bristol Myers Squibb Co | N/A | $113.3B |
Frequently asked questions
What is Supernus Pharmaceuticals's PE ratio?
The price to earnings ratio for SUPN stock as of Feb 21, 2025, stands at 30.6.
What is the 3-year average PE ratio for Supernus Pharmaceuticals (SUPN)?
Over the last 3 years, the average PE ratio for SUPN stock is 203.66.
What is the 5-year average PE ratio for Supernus Pharmaceuticals (SUPN)?
Over the last 5 years, the average PE ratio for SUPN stock is 119.38.
What is the highest PE ratio for SUPN?
The highest quarterly PE ratio in the last ten years has been 1,447 and it was in the Dec 2023 quarter.
How does the current PE ratio for SUPN compare to its historical average?
The current PE ratio of SUPN is 60% lower than the 10-year historical average.
How is SUPN's PE ratio calculated (Supernus Pharmaceuticals PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Feb 21, 2025), Supernus Pharmaceuticals's share price is $33.05. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.08. Therefore, Supernus Pharmaceuticals's price to earnings ratio for today is 30.6. PE RATIO(30.6) = STOCK PRICE($33.05) / TTM EPS($1.08)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.